Data as of Sep 26, 2026 · Based on 4,029,442 AI responses across 13,338 prompts · See how Parse measures this
AspyreRxclicktherapeutics.comClick Therapeutics develops software-enhanced drugs (prescription digital therapeutics) that pair digital behavioral therapy with pharmacotherapy to treat diseases with neurological or behavioral components. Its AspyreRx is an FDA-authorized prescription digital therapeutic that provides cognitive behavioral therapy for adults with type 2 diabetes, used in conjunction with standard care (with links to metabolic indications such as MASH). The company maintains a diverse pipeline of CT-programs across indications including MDD, migraine, schizophrenia, OUD, MS, obesity, oncology, and insomnia, spanning from discovery to pivotal/regulatory stages to deliver software-enabled treatments.
Click TherapeuticsAspyreRxParse Score
No contexts measured yet.
Excerpts where AspyreRx appeared in the AI's answer
AspyreRx: Developed by Better Therapeutics, this is notably the first prescription-only digital behavioral therapeutic cleared by the FDA specifically for adults with type 2 diabetes.
AspyreRx™: This is a notable milestone as the first FDA-cleared prescription digital therapeutic delivering cognitive behavioral therapy (CBT) specifically for adults with type 2 diabetes.
